Ribeiro Marcelo L, Vitiello Lea, Miranda Maira C B, Benvengo Yune H B, Godoy Anita P O, Mendonca Sergio, Pedrazzoli José
Clinical Pharmacology and Gastroenterology Unit, São Francisco University Medical School, Bragança Paulista, SP, Brazil.
Ann Clin Microbiol Antimicrob. 2003 Nov 21;2:11. doi: 10.1186/1476-0711-2-11.
Resistance of Helicobacter pylori to clarithromycin has been associated with A2142G and A2143G point mutations in the 23S rRNA gene. Thus, the purpose of the present study was to determine the prevalence of each mutation in 52 clarithromycin-resistant H. pylori strains and to characterize the influence each type of mutation on the MIC.
The MIC for clarithromycin was determined by the agar dilution method, and the point mutations of H. pylori were detected by PCR followed by restriction fragment length polymorphism.
Clarithromycin MICs ranged from 2 to >256 microgram ml-1 among the 52 strains included in this study. Both the A2142G and the A2143G mutations were present in 94.2% of clarithromycin-resistant H. pylori strains examined. A relationship was observed between the presence of the A2142G mutation and the highest MIC values (p = 0.01).
In an H. pylori-infected population, the A2142G mutation may incur to a greater probability of treatment failure if clarithromycin is used.
幽门螺杆菌对克拉霉素的耐药性与23S rRNA基因中的A2142G和A2143G点突变有关。因此,本研究的目的是确定52株对克拉霉素耐药的幽门螺杆菌菌株中每种突变的发生率,并描述每种突变类型对最低抑菌浓度(MIC)的影响。
采用琼脂稀释法测定克拉霉素的MIC,通过聚合酶链反应(PCR)及限制性片段长度多态性检测幽门螺杆菌的点突变。
在本研究纳入的52株菌株中,克拉霉素的MIC范围为2至>256微克/毫升。在检测的对克拉霉素耐药的幽门螺杆菌菌株中,94.2%同时存在A2142G和A2143G突变。观察到A2142G突变的存在与最高MIC值之间存在相关性(p = 0.01)。
在幽门螺杆菌感染人群中,如果使用克拉霉素,A2142G突变可能导致治疗失败的可能性更大。